Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Holt

Showing results (71-80 of 605) with videos related to

Pageof 61
Sort By:
Transplantation Proceedings|May 20, 1999
Bioequivalence criteria for cyclosporineA Johnston, D W Holt
Transplantation Proceedings|December 20, 2000
The impact of cyclosporin formulation on clinical outcomesD W Holt, A Johnston
British Journal of Clinical Pharmacology|November 30, 2013
Substandard drugs: a potential crisis for public healthAtholl Johnston, David W Holt
Therapeutic Drug Monitoring|December 1, 1995
Cyclosporin A: analytical methodology and factors affecting therapeutic drug monitoringD W Holt, A Johnston
British Journal of Hospital Medicine|April 3, 1996
Immunotherapy in organ transplantationD W Holt, A Johnston
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1993
External quality assessment scheme for cyclosporin in body fluidsA Johnston, D W Holt
Transplantation|December 15, 1995
Cyclosporine dosingA Johnston, D W Holt
Southern Medical Journal|January 1, 1986
Gastric pneumatosis intestinalis associated with cholangiocarcinomaR W Holt, J Dekker
Clinical Chemistry|July 1, 1989
The relevance of pharmacokinetics to monitoring new antiarrhythmicsD W Holt, A Johnston
American Journal of Cardiac Imaging|December 1, 1991
Noninvasive assessment of left ventricular functionW W Holt, R D White
Pageof 61

Showing results (71-80 of 605) with videos related to

Sort By:
Pageof 61
Transplantation Proceedings|May 20, 1999
Bioequivalence criteria for cyclosporineA Johnston, D W Holt
Transplantation Proceedings|December 20, 2000
The impact of cyclosporin formulation on clinical outcomesD W Holt, A Johnston
British Journal of Clinical Pharmacology|November 30, 2013
Substandard drugs: a potential crisis for public healthAtholl Johnston, David W Holt
Therapeutic Drug Monitoring|December 1, 1995
Cyclosporin A: analytical methodology and factors affecting therapeutic drug monitoringD W Holt, A Johnston
British Journal of Hospital Medicine|April 3, 1996
Immunotherapy in organ transplantationD W Holt, A Johnston
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1993
External quality assessment scheme for cyclosporin in body fluidsA Johnston, D W Holt
Transplantation|December 15, 1995
Cyclosporine dosingA Johnston, D W Holt
Southern Medical Journal|January 1, 1986
Gastric pneumatosis intestinalis associated with cholangiocarcinomaR W Holt, J Dekker
Clinical Chemistry|July 1, 1989
The relevance of pharmacokinetics to monitoring new antiarrhythmicsD W Holt, A Johnston
American Journal of Cardiac Imaging|December 1, 1991
Noninvasive assessment of left ventricular functionW W Holt, R D White
Pageof 61